Krohn K - Search Results

1

Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells.

Grusch M, Rosenberger G, Fuhrmann G, Braun K, Titscher B, Szekeres T, Fritzer-Skekeres M, Oberhuber G, Krohn K, Hengstschlaeger M, Krupitza G, Jayaram HN. Grusch M, et al. Among authors: krohn k. Cell Death Differ. 1999 Aug;6(8):736-44. doi: 10.1038/sj.cdd.4400546. Cell Death Differ. 1999. PMID: 10467347

2

Metabolism and disposition of the novel antileukaemic drug, benzamide riboside, in the isolated perfused rat liver.

Salamon A, Hagenauer B, Thalhammer T, Szekeres T, Krohn K, Jayaram HN, Jäger W. Salamon A, et al. Among authors: krohn k. Life Sci. 2001 Oct 12;69(21):2489-502. doi: 10.1016/s0024-3205(01)01329-7. Life Sci. 2001. PMID: 11693257

3

Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.

Jayaram HN, Gharehbaghi K, Jayaram NH, Rieser J, Krohn K, Paull KD. Jayaram HN, et al. Among authors: krohn k. Biochem Biophys Res Commun. 1992 Aug 14;186(3):1600-6. doi: 10.1016/s0006-291x(05)81591-8. Biochem Biophys Res Commun. 1992. PMID: 1354960

4

Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.

Gharehbaghi K, Sreenath A, Hao Z, Paull KD, Szekeres T, Cooney DA, Krohn K, Jayaram HN. Gharehbaghi K, et al. Among authors: krohn k. Biochem Pharmacol. 1994 Oct 7;48(7):1413-9. doi: 10.1016/0006-2952(94)90565-7. Biochem Pharmacol. 1994. PMID: 7945441

5

Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase.

Gharehbaghi K, Paull KD, Kelley JA, Barchi JJ Jr, Marquez VE, Cooney DA, Monks A, Scudiero D, Krohn K, Jayaram HN. Gharehbaghi K, et al. Among authors: krohn k. Int J Cancer. 1994 Mar 15;56(6):892-9. doi: 10.1002/ijc.2910560623. Int J Cancer. 1994. PMID: 7907081

6

Metabolism and action of benzamide riboside in Chinese hamster ovary cells.

Saunders PP, Arimilli S, Krohn K, Muhs MA, Alvarez E, Surve-lyer R. Saunders PP, et al. Among authors: krohn k. Anticancer Drugs. 1996 Jan;7(1):93-9. doi: 10.1097/00001813-199601000-00011. Anticancer Drugs. 1996. PMID: 8742104

7

Chemical synthesis of benzamide riboside.

Krohn K, Dörner H, Zukowski M. Krohn K, et al. Curr Med Chem. 2002 Apr;9(7):727-31. doi: 10.2174/0929867024606876. Curr Med Chem. 2002. PMID: 11966435

8

Diethylstilbestrol-linked cytotoxic agents: synthesis and binding affinity for estrogen receptors.

Krohn K, Kulikowski K, Leclercq G. Krohn K, et al. J Med Chem. 1989 Jul;32(7):1532-8. doi: 10.1021/jm00127a022. J Med Chem. 1989. PMID: 2738889

9

Hexestrol-linked cytotoxic agents: synthesis and binding affinity for estrogen receptors.

Köhle H, Krohn K, Leclercq G. Köhle H, et al. Among authors: krohn k. J Med Chem. 1989 Jul;32(7):1538-47. doi: 10.1021/jm00127a023. J Med Chem. 1989. PMID: 2544725

10

Synthesis and cytotoxic activity of C-glycosidic nicotinamide riboside analogues.

Krohn K, Heins H, Wielckens K. Krohn K, et al. J Med Chem. 1992 Feb 7;35(3):511-7. doi: 10.1021/jm00081a012. J Med Chem. 1992. PMID: 1738143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

883 results

Search Page

Filters